Security key
92764N102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 37,861,951
- Total 13F value
- $1,297,525,769
- Share change
- -225,215
- Put/Call ratio
- 89%
- SEC-reported price per share
- $34.27
- Number of holders
- 61
- Value change
- -$4,041,452
- Number of buys
- 42
- Number of sells
- 16
- Shares outstanding
- 168,677,036
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2020
Institutions
61
Top holders
10
VIR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92764N102
Recent filing periods:
Ownership snapshot
Top reported holders of VIR - Vir Biotechnology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
31 Dec 2019
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership
Top 5
SB INVESTMENT ADVISERS (UK) LTD
13%
Temasek Holdings (Private) Ltd
3.3%
ICONIQ Capital, LLC
2.1%
Alphabet Inc.
0.99%
Capital International Investors
0.58%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
13%
|
$284,405,000
22,616,666 shares
|
— | 31 Dec 2019 |
| Temasek Holdings (Private) Ltd |
13F
Company
|
3.3%
|
$69,162,000
5,499,999 shares
|
— | 31 Dec 2019 |
| ICONIQ Capital, LLC |
13F
Company
|
2.1%
|
$45,042,000
3,583,333 shares
|
— | 31 Dec 2019 |
| Alphabet Inc. |
13F
Company
|
0.99%
|
$20,958,000
1,666,666 shares
|
— | 31 Dec 2019 |
| Capital International Investors |
13F
Company
|
0.58%
|
$12,365,000
983,300 shares
|
— | 31 Dec 2019 |
| INDUS CAPITAL PARTNERS, LLC |
13F
Company
|
0.4%
|
$8,575,000
681,936 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
61
Shares
37,861,951
Rows available
61
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q1 2020 Across Filers
Q1 2020 holders
61
Q1 2020 holders
61
Holder diff
0
| Investor | Q1 2020 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q1 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend